Intestinal cytokine liberation after gut ischemia in the rat - Investigations in the Ussing chamber system;Intestinale Zytokinfreisetzung nach Darmischamie in der Ratte - Untersuchungen im Ussing-Kammersystem

Zeitschrift fur Gastroenterologie

Volumn 34, Issue 12, 1996, Pages 783-790

  Grotz, M ^a   Regel, G ^a   Schratt, H E ^a   Seekamp, A ^a   Pape, H Ch ^a   Tscherne, H ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

interleukin 6; intestinal ischemia; multiple organ failure; tumor necrosis factor; Ussing chamber

Indexed keywords

CYTOKINE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BYPASS SURGERY; CONTROLLED STUDY; HEMORRHAGIC SHOCK; INTESTINE ISCHEMIA; MALE; MULTIPLE ORGAN FAILURE; NONHUMAN; RAT; REPERFUSION; SUPERIOR MESENTERIC ARTERY OBSTRUCTION; ANIMAL; BACTERIAL TRANSLOCATION; CELL MEMBRANE POTENTIAL; ENTEROBACTER INFECTION; ILEUM; IMMUNOLOGY; INTESTINE MUCOSA; ISCHEMIA; MESENTERIC BLOOD VESSEL OCCLUSION; METABOLISM; PHYSIOLOGY; REPERFUSION INJURY; SPRAGUE DAWLEY RAT; SUPERIOR MESENTERIC ARTERY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VASCULARIZATION;

ANIMALS; BACTERIAL TRANSLOCATION; CYTOKINES; ESCHERICHIA COLI INFECTIONS; ILEUM; INTERLEUKIN-6; INTESTINAL MUCOSA; ISCHEMIA; MALE; MEMBRANE POTENTIALS; MESENTERIC ARTERY, SUPERIOR; MESENTERIC VASCULAR OCCLUSION; MULTIPLE ORGAN FAILURE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030332066     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Deitch EA. Multiple organ failure: pathophysiology and potential future therapy. Ann Surg 1992; 216: 117-34
2. Granger DN Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. Am J Physiol 1988; 255: H1269-75
3. Kubes P, Hunter J, Granger DN Ischemia/reperfusion-induced feline intestinal dysfunction: importance of granulocyte recruitment. Gastroenterology 1992; 103. 807-12
4. Kubes P Ischemia-reperfusion in feline small intestine: a role for nitric oxide. Am J Physiol 1993, 264: G143-9
5. Haglund U. Gut ischemia Gut 1994; (suppl. 1), S73-6
6. Redl H. Schlag G. Bahrami S et al The cytokine network in trauma and sepsis I. TNF and IL-8. In Schlag G, Redl H (eds.). Pathophysiology of shock, sepsis and organ failure Berlin, Heidelberg New York, Springer Verlag, 1993, 469-90
7. Waage A. Redl H, Schlag G, Schade U The cytokine network in trauma and sepsis II: IL-1 and IL-6 In Schlag G, Redl H (eds.) Pathophysiology of shock, sepsis and organ failure. Berlin. Heidelberg. New York, Springer Verlag. 1993, 491-501
8. Deitch EA, Xu D, Franko L, Ayala A, Chaudry IH. Evidence favoring the role of the gut as a cytokine-generating organ in rats subjected to hemorrhagic shock. Shock 1994; 1: 141-6
9. Grotz MRW, Ding J, Guo W, Huang Q. Deitch EA Comparison of plasma cytokine levels in rats subjected to superior mesenteric artery occlusion or hemorrhagic shock Shock 1995, 3. 362-8
10. Shenkar R, Abraham E. Effects of hemorrhage on cytokine gene transcription. Lymphokine and Cytokine Research 1993, 12: 237-47
11. Shenkar R, Chang TH, Abraham E. Cytokine expression in Peyer's patches following hemorrhage and resuscitation. Shock 1994; 1: 25-30
12. Smith SD, Cardona MA, Wishnev SA, Kurkchabasche AG, Rowe MI. Unique characteristics of the intestinal mucosal barrier. J Ped Surg 1992, 27: 333-8
13. Deitch EA, Maejima K, Berg RD. Effect of oral antibiotics and bacterial overgrowth on the translocation of the Gl-tract microflora in burned rats. J Trauma 1985; 25: 385-92
14. Jovov B, Wills NK, Lewis SA. A spectroscopic method for assessing confluence of epithelial cell cultures. Am J Physiol 1991; 261: C1196-203
15. Espevik T, Nissen-Meyer J. A. Highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods 1989, 95. 99-105
16. van Snick L, Cayphas S, Vink A. Purification and NH2-terminal amino acid dequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. Proc Natl Acad Sci USA 1989; 83: 9679-83
17. Mizel SB Production and quantitation of lymphocyte-activating factor (interleukin 1) In: Herscowitz HB, Holden HT, Bellanti JA, Ghaffar A (eds.). Manual of macrophage methodology. New York, Dekker, 1981, 407-16
18. Go LL, Ford HR, Watskins SC et al. Quantative and morphologic analysis of bacterial translocation in neonates Arch Surch 1994, 129: 1184-90
19. Go LL, Healey PJ, Watskins SC, Simmons RL, Rowe MI. The effect of endotoxin of intestinal mucosal permeability to bacteria in vitro. Arch Surg 1995, 130: 53-9
20. Deitch EA, Xu D, Naruhn MB et al. Elemental diet and IV-TPN-induced bacterial translocation is associated with loss of intestinal mucosal barrier function against bacteria Crit Care Med (im Druck)
21. Bitterman H, Kinarty A, Lazarovich H, Lahat N. Acute release of cytokines is proportional to tissue injury induced by surgical trauma and shock in rats J Clin Immunol 1991, 11: 184-92
22. Caty MG, Guice KS, Oldham KT, Remick DG, Kunkel SI. Evidence for tumor necrosis factor-induced pulmonary microvascular injury after intestinal ischemia-reperfusion injury. Ann Surg 1990; 212: 694-700
23. Eckmann L, Kagnoff MF, Fierer J. Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry. Infect Immun 1993, 61: 4569-74
24. Eckmann L, Jung HC. Schürer-Maly C et al. Differential cytokine expression of human intestinal epithelial cell lines: regulated expression of interleukin-8. Gastroenterology 1993, 105: 1689-97
25. McGee DW, Beagley KW, Aicher WK, McGhee JR. Transforming growth factor-Β enhances interleukin-6 secretion by intestinal epithelial cells. Immunology 1992; 77. 7-12
26. McGee DW, Beagley KW, Aicher WK, McGhee JR. Transforming growth factor-Β and IL-1Βact in synergy to enhance IL-6 secretion by the intestinal epithelial cell line, IEC-6. J Immunol 1993; 151 970-8
27. Gibbons RJ. Review and discussion of the role of mucus in mucosal defense. In: Strober W, Hanson LA, Sell KW (eds ) Recent advances in mucosal immunity. New York, Raven Press, 1982, 343-52
28. Haglund U, Bulkley GB, Granger DN. On the pathophysiology of intestinal ischemic injury Acta Chir Scand 1989; 153: 321-4
29. Parks DA, Granger DN. Contribution of ischemia and reperfusion to mucosal lesion formation. Am J Physiol 1986; 250. G749-58
30. Fong Y, Lowry SF. Cytokines in the cellular response to injury and infection In: Wilmore DW, Brennan M, Harken A, Hölcroft J, Meakins JC (eds.) Care of the surgical patient. Scientific American, Chapter 7, Vol 1, Section 4
31. Dokter WH. Dijkstra AJ. Koopmans SB et al. G(Anh)MTetra, a natural bacterial cell breakdown product induces interleukin-1Β and interleukin-6 expression in human monocytes A study of the molecular mechanisms involved in inflammatory cytokine expression. J Biol Chem 1994; 269: 4201-6
32. Mattson E, Verhage L, Rollof J et al. Peptidoglykan and teichod acid from Staphylococcus epidermidis stimulate human monocytes to release tumor necrosis factor-á, interleukin-1Β and interleukin-6. FEMS Immu Med Microbiol 1993; 7. 281-7
33. Rabin RL, Bieber MM, Teng NN. Lipopolysaccharide and peptidoglycan share binding sites on human peripheral blood monocytes. J Infect Dis 1993; 168: 135-42
34. Martinez-Pellus AE, Merino P, Bru M et al Can selective gut decontamination avoid the endotoxemia and cytokine activation prompted by cardiopulmonary bypass? Crit Care Med 1993; 21: 1684-91
35. Fox MA, Peterson S, Fabri BM, van Saene HKF, Williets T. Selective decontamination of the digestive tract in cardiac surgical patients. Crit Care Med 1991, 19: 1486-90
36. Fink MP. Selective digestive decontamination: a gut issue for the nineties. Crit Care Med 1992, 20: 559-62
37. van Saene HKF, Stoutenbeek, Stoller JK, Fink MP Selective decontamination of the digestive tract in the intensive care unit. Crit Care Med 1992; 209: 691-703